[go: up one dir, main page]

CA2321256A1 - Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs - Google Patents

Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs Download PDF

Info

Publication number
CA2321256A1
CA2321256A1 CA002321256A CA2321256A CA2321256A1 CA 2321256 A1 CA2321256 A1 CA 2321256A1 CA 002321256 A CA002321256 A CA 002321256A CA 2321256 A CA2321256 A CA 2321256A CA 2321256 A1 CA2321256 A1 CA 2321256A1
Authority
CA
Canada
Prior art keywords
psp94
rhu
seq
human
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002321256A
Other languages
English (en)
Inventor
Unknown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Procyon Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyon Biopharma Inc filed Critical Procyon Biopharma Inc
Priority to CA002321256A priority Critical patent/CA2321256A1/fr
Priority to CA002355334A priority patent/CA2355334A1/fr
Priority to AT01981990T priority patent/ATE479755T1/de
Priority to AU2002213691A priority patent/AU2002213691B2/en
Priority to DE60142979T priority patent/DE60142979D1/de
Priority to JP2002536061A priority patent/JP4520091B2/ja
Priority to AU1369102A priority patent/AU1369102A/xx
Priority to US09/977,406 priority patent/US7053058B2/en
Priority to ES01981990T priority patent/ES2351783T3/es
Priority to EP01981990A priority patent/EP1326981B1/fr
Priority to CA2359650A priority patent/CA2359650C/fr
Priority to PCT/CA2001/001463 priority patent/WO2002033090A2/fr
Publication of CA2321256A1 publication Critical patent/CA2321256A1/fr
Priority to US11/240,937 priority patent/US7655631B2/en
Priority to US12/692,225 priority patent/US8551951B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002321256A 2000-10-16 2000-10-16 Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs Abandoned CA2321256A1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CA002321256A CA2321256A1 (fr) 2000-10-16 2000-10-16 Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs
CA002355334A CA2355334A1 (fr) 2000-10-16 2001-08-20 Preparations pharmaceutiques et methodes visant a inhiber la croissance de tumeurs
US09/977,406 US7053058B2 (en) 2000-10-16 2001-10-15 Pharmaceutical preparations and methods for inhibiting tumors
EP01981990A EP1326981B1 (fr) 2000-10-16 2001-10-15 Preparations pharmaceutiques et methodes d'inhibition de tumeurs
DE60142979T DE60142979D1 (de) 2000-10-16 2001-10-15 Pharmazeutische zubereitungen und methoden zur hemmung von tumoren
JP2002536061A JP4520091B2 (ja) 2000-10-16 2001-10-15 腫瘍抑制のための医薬製剤及び方法
AU1369102A AU1369102A (en) 2000-10-16 2001-10-15 Pharmaceutical preparations and methods for inhibiting tumors
AT01981990T ATE479755T1 (de) 2000-10-16 2001-10-15 Pharmazeutische zubereitungen und methoden zur hemmung von tumoren
ES01981990T ES2351783T3 (es) 2000-10-16 2001-10-15 Preparaciones farmacéuticas y procedimientos para la inhibición de tumores.
AU2002213691A AU2002213691B2 (en) 2000-10-16 2001-10-15 Pharmaceutical preparations and methods for inhibiting tumors
CA2359650A CA2359650C (fr) 2000-10-16 2001-10-15 Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs
PCT/CA2001/001463 WO2002033090A2 (fr) 2000-10-16 2001-10-15 Preparations pharmaceutiques et methodes d'inhibition de tumeurs
US11/240,937 US7655631B2 (en) 2000-10-16 2005-09-30 Pharmaceutical preparations and methods for inhibiting tumors
US12/692,225 US8551951B2 (en) 2000-10-16 2010-01-22 Pharmaceutical preparations and methods for inhibiting tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002321256A CA2321256A1 (fr) 2000-10-16 2000-10-16 Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs

Publications (1)

Publication Number Publication Date
CA2321256A1 true CA2321256A1 (fr) 2002-04-16

Family

ID=4167254

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002321256A Abandoned CA2321256A1 (fr) 2000-10-16 2000-10-16 Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs

Country Status (2)

Country Link
CA (1) CA2321256A1 (fr)
ES (1) ES2351783T3 (fr)

Also Published As

Publication number Publication date
ES2351783T3 (es) 2011-02-10

Similar Documents

Publication Publication Date Title
US8551951B2 (en) Pharmaceutical preparations and methods for inhibiting tumors
CA2138122C (fr) Preparations pharmaceutiques pour l'inhibition de tumeurs associees a l'adenocarcinome de la prostate, ainsi qu'au cancer du sein et de l'estomac
KR101364374B1 (ko) 생활성 ｆｕｓ1 펩티드 및 나노입자-폴리펩티드 복합체
US5443967A (en) DNA encoding the cancer associated SCM recognition factor
US5320947A (en) Immune reactivity to expressed activated oncogenes for diagnosis of malignancy
KR100336452B1 (ko) 앤지오스타틴및맥관형성억제를위한이의사용방법
AU2002213691A1 (en) Pharmaceutical preparations and methods for inhibiting tumors
RU2684911C2 (ru) Пептид, полученный из hsp70, фармацевтическая композиция для лечения или профилактики рака, содержащая такой пептид, индуктор иммунного ответа и способ получения антиген-презентирующей клетки
WO2018166119A1 (fr) Polypeptide ou dérivé de celui-ci et son utilisation dans la préparation d'un médicament pour le traitement d'une tumeur
CA2321256A1 (fr) Preparations pharmaceutiques, et methodes visant a inhiber la croissance de tumeurs
JP2001526891A (ja) ママスタチンのヌクレオチドおよびタンパク質配列およびその使用法
CN118126198A (zh) Dav及其在制备恶性黑色素瘤药物中的应用
CN105175498A (zh) 一种宫颈癌相关的热休克蛋白复合物及其应用
CA2359650C (fr) Preparations et methodes pharmaceutiques pour inhiber la croissance de tumeurs
JP2008519839A (ja) 癌細胞におけるアポトーシスの増加のための組成物および方法
US6617432B1 (en) Nuclear matrix proteins polynucleotide sequences encoding them and their use
EP0681480B1 (fr) Vaccins a base de recognine
CN101161283A (zh) CMTM1-v17的新应用及其拮抗剂
CN104211773A (zh) 食管癌相关肽和热休克蛋白形成的复合物及其应用
JP2001523087A (ja) 腎核マトリックスタンパク質、それらをコードするポリヌクレオチド配列およびそれらの用途

Legal Events

Date Code Title Description
FZDE Dead